TABLE 1.
Polysaccharides from medicinal plant with antioxidation and anti-diabetic effects.
Polysaccharide source | Monosaccharides composition | Models | Administration | Mechanism | Positive control | Reference |
---|---|---|---|---|---|---|
Abelmoschus esculentus (L.) Moench | Man: rha: glucuronic acid, galactosal acid, gal: ara = 3.4:3.76:24.19:6.27:8.73:3.13 | HFD combined with STZ induced mice | 200 or 400 mg/kg | ↓: TG, TC, LDL-C; MDA, body weight, and ROS | Metformin | Liao et al. (2019a) |
↑: HDL-C, SOD, GSH-Px and CAT, Nrf2, HO-1, SOD2, PI3K/AKT/GSK3β pathway | ||||||
Abelmoschus esculentus (L.) Moench | Rha: Gal: Gal A = 1.87:3.58:1.00 | HFD and STZ induced mice | 200, 400 mg/kg | ↓: ROS, MDA, caspase-3, and Bax | Metformin | Liao et al. (2019b) |
↑: SOD, Bcl-2 and CAT, Nrf2, HO-1, SOD2, AMPK/AMPK pathway | ||||||
Cyclocarya paliurus (Batal.) Iljinskaja | Glc: ara: gal: man: xyl: rha: galacturonic acid: glucuronic acid: fuc: rib = 27.90:9.68:7.67:1.93:1.67:1.26:0.72:0.66:0.17:0.16 | STZ induced diabetic rats | 1, 10 and 100 mg/kg/·d for 12 weeks | ↑: SOD, CAT, GSH-Px, and GSH | Metformin hydrochloride | Xia et al. (2020) |
↓: AGEs and TGF-β1 | ||||||
Cyclocarya paliurus (Batal.) Iljinskaja | Rha: ara: xyl: man: glu: gal | STZ induced rats | 1, 10, 100 mg/kg/d for 12 weeks | ↑:SOD, CAT, GSH-Px, GSH | Zhang et al. (2021) | |
↓: AGEs, ROS, and TGF-β1 | ||||||
Fructus Corni | Man: gal A, glc: xyl: gal: ara = 0.95:0.08:3.17:1.88:1.23:0.25 | STZ-induced diabetic rats | 800 mg/kg on 42nd day | ↑: ACT, SOD, and GSH | Metformin hydrochloride | Wang et al. (2019a) |
Astragali radix | Glc, gal A, ara, gal, glu A xyl | STZ induced male C57BL/6J mice | 400 mg/kg/d | ↑: SOD, GSH, CAT | (Chen et al., 2022) (Chen et al., 2018) | |
↓: MDA levels | ||||||
Hedysarum alpinum L. | ob/ob mice | 50, 100, and 200 mg/kg/d | ↓: Keap1 signalling | lipoic acid | He et al. (2022) | |
↑: Nrf2 signalling | ||||||
Hedysarum alpinum L. | HG induced Schwann cells | 30, 60, 120, and 240 mg/L | ↓: MDA | He et al. (2022) | ||
↑: GCLC, GR | ||||||
Morus alba L. | STZ+HFD induced rats | ↓: MDA | Liu et al. (2017) | |||
↑: SOD, CCO and SDH | ||||||
Mulberry leaves | STZ induced diabetic rats | 50–200 mg/kg for 5weeks | ↓: MDA | Li et al. (2022) | ||
↑: SOD | ||||||
Dendrobium officinale Kimura & Migo | D-Glcp: D-Manp = 1.00:4.41. 190 kDa | male wistar rats | 20, 40, 80, and 160 mg/kg/d for 8 weeks | ↑: SOD, CAT, and T-AOC | Metformin | Yang et al. (2020a) |
Polygonatum sibiricum Redouté | STZ induced rats | 200, 400 and 800 mg/kg | ↑: insulin | Wang et al. (2017d) | ||
↓: MDA, blood glucose | ||||||
Polygonatum sibiricum Redouté | HG-induced ARPE-19 cells | ↓: MDA, ROS, bcl-2 | Wang et al. (2022) | |||
↑: SOD and GPx, Bax, caspase-3 activity, Nrf2/HO-1 pathway | ||||||
Polygonatum sibiricum Redouté | 1 μmol/L insulin and 25 mmol/L glucose induced 3T3-L1 adipocytes | 50, 100, 250, 500 μg/mL | ↑: Nrf2,HO-1 | Cai et al. (2019) | ||
↓: IL-6, IL-1βand TNF-α | ||||||
Codonopsis lanceolata (Siebold & Zucc.) Benth. & Hook.f. ex Trautv | Rha: Ara:xyl:man: gal: glc: Gal A: glu A = 0.17:1:0.12:0.05:0.26:2.32:0.19:0.95 | HFHS diet-fed mice | 100 mg/kg | ↓: MDA | Zhang et al. (2020) | |
↑:GSH/GSSG ratio, SOD, CAT, Nrf2 signalling | ||||||
Dipsacus asper Wall. ex DC. | D-glu | STZ-induced diabetic rats | 100 and 300 mg/kg for 4 weeks | Downregulated oxidative stress and glycation end products-receptor | Metformin | Li et al. (2019a) |
Ophiopogon japonicus (Thunb.) Ker Gawl | Ara: Glu: gal = 1:16:8 | STZ induced mice | 150 mg/kg/d for 28 days | ↑: GPx and SOD | Metformin | Chen et al. (2013) |
Ophiopogon japonicus (Thunb.) Ker Gawl | RAW264.7 cells induced by nickel | 10, 50, and 100 μg/mL for 24 h | ↓: DPPH, ABTS, NO, iNOS, COX2 | Lin et al. (2020) | ||
Rehmannia glutinosa (Gaertn.) DC. | Rha: ara: man: glc: gal = 1.00:1.26:0.73:16.45:30.40; 63.5 kDa | STZ-induced diabetic mice | 20, 40 and 80 mg/kg/day | ↑: GPx and SOD activities | Metformin | Zhou et al. (2015a) |
↓: MDA, IL-6, TNF-α, and MCP-1 | ||||||
Psidium guajava L | polysaccharides (≥80.99 kDa) and low molecular weight polysaccharides (3.64 kDa) | STZ and HFD induced mice | 100 mg/kg, 200 mg/kg/d | ↑: GPx and SOD activities | Acarbose | Luo et al. (2019) |
Apostichopus japonicus | →4GlcA (Fuc2S,4Sα1→3)β1→3GalNAc4S6Sβ1→ | HFD for 12 weeks | 50 mg/kg/day | ↑: P- IRS1, Akt, and AMPK | Metformin | Chen et al. (2019b) |
Pueraria lobata (Willd.) Ohwi (Fabaceae) | db/db mice | 100 or 200 mg/kg for 6 weeks | ↓: PEPCK, G6PC, FOXO1, SREBP-1, and ACC | Rosiglitazone | Luo et al. (2021) | |
↑: GS, Akt2, PI3K, GLUT2, PPARa, and LDLR | ||||||
Lycium barbarum L | ara, glc, gal, man, rha, xyl, gal A | STZ-induced diabetic mice | 50, 100, 200 mg/kg for 30 days | ↓: MDA | Li (2007) | |
↑: SOD | ||||||
STZ-included mice | 10, 20, and 40 mg/kg | ↓: Caspase-3 | Sildenafil citrate | Shi et al. (2017) | ||
↑: Bcl-2/Bax | ||||||
Euryale ferox Salisb. | Man, GlcA, Rha, Glc, Gal and Ara at a molar ratio of 0.12:0.01:9.57:0.41:1.00:0.24 | alloxan-induced hyperglycemic mice | 100,200,400 mg/kg/d | ↑: CAT, SOD, oral glucose tolerance, hepatic glycogen content and GSH-Px | metformin hydrochloride | Wu et al. (2017a) |
↓: MDA, glucose level increase | ||||||
Physalis alkekengi var. franchetii Makino | Alloxan-induced hyperglycemic mice | 200, 400, and 800 mg/kg | ↑: PI3K, Akt and GLUT4 mRNA; Hypoglycaemic; protecting and reverse β-cells from necrosis | Acarbose | Guo et al. (2017) | |
Schisandra sphenanthera Rehder & E.H.Wilson | Rha:Ara:Man:Gal:Glc = 13.52:5.69:3.92:41.28:35.59 | STZ induced rats | 100,200,400 mg/kg/d | ↑: GLUT-4; mitigate the insulin resistance; hpyerglycemic; improving the glucose tolerance | glibenclamide | Niu et al. (2017) |
Paeonia × suffruticosa Andrews | D-glucose: L-arabinose = 3.31:2.25 | high-sugar diet and STZ treatment rats | 80, 160 mg kg | ↓: serum creatinine, AGEs/RAGE | Lian et al. (2021) | |
Moutan Cortex | 200 μg/mL AGEs induced human umbilical vein endothelial cells for 24 h | 64.5 μg/mL | ↓: ROS | Aminoguanidine | Lian et al. (2021) | |
Arctium lappa L | Gal: Man: Glc: Rha: Xyl: GlcN: GlcA = 6:6.4:26.5: 3.3:26.2:7 2 | high-sugar, HFD, and STZ | 100, 200 mg/kg for 40 days | ↓: PKC expression, MDA, and NF-κB pathway | Li et al. (2019b) | |
↑: SOD and GSH px | ||||||
Anoectochilus roxburghii (Wall.) Lindl | HFD induced mice | 100, 200, and 400 mg/kg | ↑: GST, GPX, GST and SOD | Chen et al. (2021) | ||
↓: MDA, ATP | ||||||
Buddleja officinalis Maxim | glucose, galactose, fucose, glucuronic acid, and galacturonic acid in a ratio of 6.75 : 3.33 : 1.79 : 1.42 : 1.00 | db/db mice | 40,80,160 μg/mL | ↑: HO-1, NQO1, SOD and Nrf2/ARE signalling pathway | Zhu et al. (2022) | |
↓: CD34, ROS | ||||||
Opuntia milpa alta | Xylose: arabinose: galactose = 23:36:15 | alloxan-treated INS-1 cells | 50, 100, and 200 μg/mL | ↑: Bcl-2, MDA, and NO | Li et al. (2020b) | |
↓: Bax, ROS, caspase-3, caspase-9 | ||||||
Astragalus mongholicus Bunge | D-glu: D-gal: L-ara = 1.75:1.63:1 | HG induced H9C2 cells for 24 h | 0.1,1,10,100 μg/mL | ↑: SOD2, GSH-Px | Sun et al. (2019) | |
↓: ROS, MDA, and NO |